{"Clenbuterol":{"RelatedTo":["Beta-2 adrenergic receptor","Tumor necrosis factor"],"Synonym":["Clenbuterolum (inn-latin)"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB01407","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB01407","Definition":"A substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. (PubChem) Pharmacology: Clenbuterol is a substituted phenylaminoethanol that has beta-2 adrenomimetic properties at very low doses. It is used as a bronchodilator in asthma. Although approved for use in some countries, as of fall, 2006, clenbuterol is not an ingredient of any therapeutic drug approved by the U.S. Food and Drug Administration. Mechanism of action: Not Available Drug type: Approved. Small Molecule. Drug category: Adrenergic beta-Agonists. Bronchodilator Agents. Sympathomimetics"}}